Simhadri Prathap Kumar, Contractor Renish, Chandramohan Deepak, McGee Matthew, Nangia Udit, Atari Mohammad, Bushra Syed, Kapoor Sanjana, Velagapudi Ramya Krishna, Vaitla Pradeep K
Internal Medicine/Nephrology, Advent Health, Daytona Beach, FL 32117, United States.
Department of Medicine, FSU College of Medicine, Daytona Beach, FL 32117, United States.
World J Nephrol. 2025 Jun 25;14(2):100530. doi: 10.5527/wjn.v14.i2.100530.
Malakoplakia is a rare chronic granulomatous disease associated with gram-negative infection, predominantly by It is induced by defective phagolysosomal activity of the macrophages. Malakoplakia commonly affects the urinary bladder but has been shown to affect any solid organ, including the native and transplanted kidney. However, isolated malakoplakia of the kidney allograft is rare. Transplant recipients with compromised immune systems are more likely to develop malakoplakia.
We report three cases of kidney allograft parenchymal malakoplakia in kidney transplant recipients on immunosuppression that were successfully managed with good outcomes. We described the clinical characteristics of all the kidney allograft malakoplakia cases documented in the literature. A total of 55 cases of malakoplakia were reported in recipients with a history of kidney transplant. A total of 27 recipients had malakoplakia involving the allograft, and others had malakoplakia in other organs. The common presentations included allograft dysfunction, pyelonephritis, and allograft or systemic mass. Most recipients had favorable outcomes with appropriate management that included prolonged antibiotic therapy and adjustment of immunosuppression. We reviewed the published literature on all the cases of malakoplakia in kidney transplant recipients so far and summarized the etiology, management, and outcomes.
This case series provides an overview of the etiology, presentation, pathogenesis, and management of malakoplakia in kidney transplant recipients.
软斑病是一种罕见的慢性肉芽肿性疾病,与革兰氏阴性菌感染相关,主要由巨噬细胞吞噬溶酶体活性缺陷所致。软斑病通常累及膀胱,但也可累及任何实体器官,包括自体肾和移植肾。然而,孤立性移植肾软斑病较为罕见。免疫系统受损的移植受者更易发生软斑病。
我们报告了3例接受免疫抑制治疗的肾移植受者发生移植肾实质软斑病的病例,经成功治疗后预后良好。我们描述了文献中记录的所有移植肾软斑病病例的临床特征。共有55例有肾移植病史的受者报告发生软斑病。其中27例受者的软斑病累及移植肾,其他受者的软斑病发生于其他器官。常见表现包括移植肾功能障碍、肾盂肾炎以及移植肾或全身肿块。大多数受者经包括延长抗生素治疗和调整免疫抑制在内的适当治疗后预后良好。我们回顾了迄今为止已发表的关于肾移植受者软斑病所有病例的文献,并总结了其病因、治疗及预后。
本病例系列概述了肾移植受者软斑病的病因、表现、发病机制及治疗。